Will JC, Galuska DA, Vinicor F, Calle EE: Colorectal cancer: another complication of diabetes mellitus?. Am J Epidemiol. 1998, 147: 816-825.
Article
CAS
PubMed
Google Scholar
Hu FB, Manson JE, Liu S, Hunter D, Colditz GA, Michels KB: Prospective study of adult onset diabetes mellitus (type 2) and risk of colorectal cancer in women. J Natl Cancer Inst. 1999, 91: 542-547. 10.1093/jnci/91.6.542.
Article
CAS
PubMed
Google Scholar
Sampson MJ, Hughes DA: Chromosomal telomere attrition as a mechanism for the increased risk of epithelial cancers and senescent phenotypes in type 2 diabetes. Diabetologia. 2006, 49 (8): 1726-1731. 10.1007/s00125-006-0322-4.
Article
CAS
PubMed
Google Scholar
Meeker AK, Hicks JL, Iacobuzio-Donahue CA: Telomere length abnormalities occur early in the initiation of epithelial carcinogenesis. Clin Cancer Res. 2004, 10: 3317-3326. 10.1158/1078-0432.CCR-0984-03.
Article
CAS
PubMed
Google Scholar
Plentz RR, Wiemann SU, Flemming P: Telomere shortening of epithelial cells characterises the adenoma-carcinoma transition of human colorectal cancer. Gut. 2003, 52: 1304-1307. 10.1136/gut.52.9.1304.
Article
CAS
PubMed
PubMed Central
Google Scholar
Deng Y, Chang S: Role of telomeres and telomerase in genomic instability, senescence and cancer. Laboratory Investigation. 2007, 87: 1071-1076. 10.1038/labinvest.3700673.
Article
CAS
PubMed
Google Scholar
Counter CM, Avilion AA, LeFeuvre CE: Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J. 1992, 11: 1921-1929.
CAS
PubMed
PubMed Central
Google Scholar
Chang S, Khoo C, Naylor M: Telomere-based crisis: functional differences between telomerase activation and ALT in tumor progression. Genes and Development. 2003, 17: 88-100. 10.1101/gad.1029903.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hanahan D: Benefits of bad telomeres. Nature. 2000, 406: 573-574. 10.1038/35020662.
Article
CAS
PubMed
Google Scholar
Hollstein M, Sidransky D, Vogelstein B: p53 mutations in human cancers. Science. 1991, 253: 49-53. 10.1126/science.1905840.
Article
CAS
PubMed
Google Scholar
Veloso M, Wrba F, Kaserer K: p53 gene status and expression of p53, mdm2, and p21Waf1/Cip1 proteins in colorectal cancer. Virchows Arch. 2000, 437: 241-247. 10.1007/s004280000255.
Article
CAS
PubMed
Google Scholar
von Zglinicki T: Role of oxidative stress in telomere length regulation and replicative senescence. Ann N Y Acad Sci. 2000, 908: 99-110.
Article
CAS
PubMed
Google Scholar
Oikawa S, Kawanishi S: Site-specific DNA damage at GGG sequence by oxidative stress may accelerate telomere shortening. FEBS Lett. 1991, 453: 365-368. 10.1016/S0014-5793(99)00748-6.
Article
Google Scholar
von Zglinicki T, Pilger R, Sitte N: Accumulation of single-strand breaks is the major cause of telomere shortening in human fibroblasts. Free Radic Biol Med. 2000, 28: 64-74. 10.1016/S0891-5849(99)00207-5.
Article
CAS
PubMed
Google Scholar
Serra V, Grune T, Sitte N, Saretzki G, von Zglinicki T: Telomere length as a marker of oxidative stress in primary human fibroblast cultures. Ann NY Acad Sci. 2000, 908: 327-330.
Article
CAS
PubMed
Google Scholar
Sampson MJ, Astley S, Richardson T, Willis G, Davies IR, Hughes DA: Increased DNA oxidative susceptibility without increased plasma LDL oxidizability in type II diabetes: effects of alpha-tocopherol supplementation. Clin Sci (Lond). 2001, 101: 235-241.
Article
CAS
Google Scholar
Rehman A, Nourooz-Zadeh J, Moller W, Tritschler H, Pereira P, Halliwell B: Increased oxidative damage to all DNA bases in patients with type II diabetes mellitus. FEBS. 1999, 448: 120-122. 10.1016/S0014-5793(99)00339-7.
Article
CAS
Google Scholar
Sampson MJ, Winterbone MS, Hughes JC, Dozio N, Hughes DA: Monocyte telomere shortening and oxidative DNA damage in type 2 diabetes. Diabetes Care. 2006, 29 (2): 283-289. 10.2337/diacare.29.02.06.dc05-1715.
Article
CAS
PubMed
Google Scholar
O'Sullivan J, Risques RA, Mandelson MT, Chen L, Brentnall TA, Bronner MP, Macmillan MP, Feng Z, Siebert JR, Potter JD, Rabinovitch PS: Telomere length in the colon declines with age: a relation to colorectal cancer?. Cancer Epidemiol Biomarkers Prev. 2006, 15 (3): 573-577. 10.1158/1055-9965.EPI-05-0542.
Article
PubMed
Google Scholar
Kinouchi Y, Hiwatashi N, Chida M, Nagashima F, Takagi S, Maekawa H, Toyota T: Telomere shortening in the colonic mucosa of patients with ulcerative colitis. J Gastroenterol. 1998, 33 (3): 343-348. 10.1007/s005350050094.
Article
CAS
PubMed
Google Scholar
Halliwell B, Gutteridge JMC: Free radicals in biology and medicine. 1999, Oxford, United Kingdom: Oxford University Press, 3
Google Scholar
Leinonen J, Lehtimaki T, Toyokuni S, Okada K, Tanaka T, Hiai H, Ochi H, Laippala P, Rantalaiho V, Wirta O, Pasternack A, Alho H: New biomarker evidence of oxidative DNA damage in patients with non-insulin-dependent diabetes mellitus. FEBS Lett. 1997, 417: 150-152. 10.1016/S0014-5793(97)01273-8.
Article
CAS
PubMed
Google Scholar
Demissie S, Levy D, Benjamin EJ, Cupples LA, Gardner JP, Herbert A: Insulin resistance, oxidative stress, hypertension, and leukocyte telomere length in men from the Framingham Heart Study. Aging Cell. 2006, 5: 325-330. 10.1111/j.1474-9726.2006.00224.x.
Article
CAS
PubMed
Google Scholar
Adaikalakoteswari A, Balasubramanyam M, Mohan V: Telomere shortening occurs in Asian Indian type 2 diabetic patients. Diabetic Med. 2005, 22: 1151-1156. 10.1111/j.1464-5491.2005.01574.x.
Article
CAS
PubMed
Google Scholar
Spyridopoulos I, Haendeler J, Urbrich C, Brummendorf TH, Oh H, Schneider MD, Zeiher AM, Dimmeler S: Statins enhance migratory capacity by upregulation of the telomere repeat binding factor TRF-2 in endothelial progenitor cells. Circulation. 2004, 110: 3136-3142. 10.1161/01.CIR.0000142866.50300.EB.
Article
CAS
PubMed
Google Scholar
Brouilette SW, Moore JS, McMahon AD, Thompson JR, Ford I, Shepherd J, Packard CJ, Samani NJ: West of Scotland Coronary Prevention Study Group. Telomere length, risk of coronary heart disease, a statin treatment in the West of Scotland Primary Prevention Study: a nested case-control study. Lancet. 2007, 369 (9556): 107-114. 10.1016/S0140-6736(07)60071-3.
Article
CAS
PubMed
Google Scholar
Markowitz SD: Aspirin and colon cancer – targeting prevention?. N Engl J Med. 2007, 356 (21): 2195-2198. 10.1056/NEJMe078044.
Article
CAS
PubMed
Google Scholar
Mira ML, Silva MM, Queiroz MJ, Manso CF: Angiotensin converting enzyme inhibitors as oxygen free radical scavengers. Free Radic Res Commun. 1993, 19 (3): 173-81. 10.3109/10715769309111600.
Article
CAS
PubMed
Google Scholar
Scribner AW, Loscalzo J, Napoli C: The effect of angiotensin-converting enzyme inhibition on endothelial function and oxidant stress. Eur J Pharmacol. 1997, 482: 95-99. 10.1016/j.ejphar.2003.10.002.
Article
Google Scholar
Khaw KT, Wareham N, Bingham S, Luben R, Welch A, Day N: Preliminary communication: glycated hemoglobin, diabetes, and incident colorectal cancer in men and women: a prospective analysis from the European prospective investigation into cancer-Norfolk study. Cancer Epidemiol Biomarkers Prev. 2004, 13 (6): 915-919.
PubMed
Google Scholar